Epigenomic effects of vitamin D in colorectal cancer.
暂无分享,去创建一个
[1] Rong Wang,et al. Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency. , 2021, Free radical biology & medicine.
[2] Kunpeng Wang,et al. Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis via KIF5B, CYP24A1, and BTG2, Respectively , 2021, Frontiers in Oncology.
[3] A. Javadmanesh,et al. A DNA methylation panel for high performance detection of colorectal cancer. , 2020, Cancer genetics.
[4] J. Manson,et al. Effect of Vitamin D3 Supplements on Development of Advanced Cancer , 2020, JAMA network open.
[5] M. Abbaszadegan,et al. Mechanisms of long non‐coding RNA function in colorectal cancer tumorigenesis , 2020, Asia-Pacific journal of clinical oncology.
[6] R. Wood,et al. Association Between Histone Deacetylase Activity and Vitamin D-Dependent Gene Expressions in Relation to Sulforaphane in Human Colorectal Cancer Cell. , 2020, Journal of the science of food and agriculture.
[7] D. Xie,et al. VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment , 2020, Signal Transduction and Targeted Therapy.
[8] M. Szyf,et al. Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma , 2020, Frontiers in Oncology.
[9] M. Szyf,et al. S‐adenosylmethionine in combination with decitabine shows enhanced anti‐cancer effects in repressing breast cancer growth and metastasis , 2020, Journal of cellular and molecular medicine.
[10] M. Szyf,et al. An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis , 2020, Bone Research.
[11] F. Casanueva,et al. Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer , 2020, Clinical Epigenetics.
[12] R. Patalano,et al. Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells , 2020, Nutrients.
[13] M. Zheng,et al. Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology , 2020, Molecular Cancer.
[14] Yi Wang,et al. Long Non-coding RNA MEG3 Activated by Vitamin D Suppresses Glycolysis in Colorectal Cancer via Promoting c-Myc Degradation , 2020, Frontiers in Oncology.
[15] A. Jemal,et al. Colorectal cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[16] Chenjing Zhu,et al. The Oncogenic and Tumor Suppressive Functions of the Long Noncoding RNA MALAT1: An Emerging Controversy , 2020, Frontiers in Genetics.
[17] A. Javadmanesh,et al. Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor , 2020, Scientific Reports.
[18] S. Christakos,et al. Vitamin D and the intestine: Review and update , 2020, The Journal of Steroid Biochemistry and Molecular Biology.
[19] A. Goel,et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential , 2020, Nature Reviews Gastroenterology & Hepatology.
[20] Guochao Liao,et al. LSD1/KDM1A inhibitors in clinical trials: advances and prospects , 2019, Journal of Hematology & Oncology.
[21] Jun Yu,et al. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications , 2019, Nature Reviews Gastroenterology & Hepatology.
[22] Yu Zhang,et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis , 2019, BMJ.
[23] Wei Wang,et al. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer , 2019, World journal of gastroenterology.
[24] Xiang Zhou,et al. The roles of microRNAs in epigenetic regulation. , 2019, Current opinion in chemical biology.
[25] J. Lulek,et al. Drug Delivery Systems for Vitamin D Supplementation and Therapy , 2019, Pharmaceutics.
[26] E. Heard,et al. Advances in epigenetics link genetics to the environment and disease , 2019, Nature.
[27] S. Rabbani,et al. DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications , 2019, Front. Oncol..
[28] J. Manson,et al. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] J. Meyerhardt,et al. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial , 2019, JAMA.
[30] M. Urashima,et al. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial , 2019, JAMA.
[31] A. Crujeiras,et al. Association between serum 25-hydroxyvitamin D and global DNA methylation in visceral adipose tissue from colorectal cancer patients , 2019, BMC Cancer.
[32] Xiaozhong Peng,et al. Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D , 2019, Cell Death & Disease.
[33] Xianling Cong,et al. CYP24A1 Inhibition Facilitates the Antiproliferative Effect of 1,25(OH)2D3 Through Downregulation of the WNT/β-Catenin Pathway and Methylation-Mediated Regulation of CYP24A1 in Colorectal Cancer Cells. , 2018, DNA and cell biology.
[34] W. Willett,et al. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts , 2018, Journal of the National Cancer Institute.
[35] Na Ta,et al. MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin , 2018, EBioMedicine.
[36] D. Goltzman. Functions of vitamin D in bone , 2018, Histochemistry and Cell Biology.
[37] H. Baba,et al. Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers , 2018, Digestion.
[38] M. Szyf,et al. Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications , 2017, Oncotarget.
[39] J. R. Tejedor,et al. Distinct chromatin signatures of DNA hypomethylation in aging and cancer , 2017, bioRxiv.
[40] M. Kerachian,et al. New insights into colorectal cancer screening and early detection tests , 2017 .
[41] B. Han,et al. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer , 2017, Cellular Physiology and Biochemistry.
[42] H. Bourbon,et al. Genome Regulation by Polycomb and Trithorax: 70 Years and Counting , 2017, Cell.
[43] S. Mukhopadhyay. Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14. , 2017, Neurotoxicology.
[44] Euan J. Rodger,et al. Epigenetic drivers of tumourigenesis and cancer metastasis. , 2017, Seminars in cancer biology.
[45] M. Kerachian,et al. Rising rates of colorectal cancer among younger Iranians: is diet to blame? , 2017, Current oncology.
[46] M. Duffy,et al. Vitamin D analogues: Potential use in cancer treatment. , 2017, Critical reviews in oncology/hematology.
[47] B. Madison,et al. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications , 2017, Disease Models & Mechanisms.
[48] Bin Guo,et al. Vitamin D and the Epigenetic Machinery in Colon Cancer. , 2017, Current medicinal chemistry.
[49] H. Fan,et al. Risk analysis of colorectal cancer incidence by gene expression analysis , 2017, PeerJ.
[50] Jing Zhu,et al. H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells , 2017, Neoplasia.
[51] A. Feinberg,et al. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis , 2017, Nature Genetics.
[52] Yoko Yamamoto,et al. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer , 2017, Oncotarget.
[53] Honghe Zhang,et al. Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review) , 2016, International journal of oncology.
[54] H. Schwarzenbach. Biological and Clinical Relevance of H19 in Colorectal Cancer Patients , 2016, EBioMedicine.
[55] G. Kullak-Ublick,et al. Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor , 2016, The Journal of Steroid Biochemistry and Molecular Biology.
[56] Xinjun Zhang,et al. Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis , 2016, Scientific Reports.
[57] Dan Zhao,et al. Clinical significance of HOTAIR expression in colon cancer. , 2016, World journal of gastroenterology.
[58] C. Rao,et al. Prevention and treatment of cancers by immune modulating nutrients. , 2016, Molecular nutrition & food research.
[59] M. Lübbert,et al. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy , 2016, Clinical Epigenetics.
[60] James E Audia,et al. Histone Modifications and Cancer. , 2016, Cold Spring Harbor perspectives in biology.
[61] Justin L. Brown,et al. Polymeric nanoparticles: the future of nanomedicine. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[62] M. Falzon,et al. Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells. , 2015, Cancer letters.
[63] M. Szyf,et al. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo , 2015, British journal of pharmacology.
[64] A. Chan,et al. Nutrients, foods, and colorectal cancer prevention. , 2015, Gastroenterology.
[65] M. Szyf,et al. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications , 2015, Cancer medicine.
[66] E. Giovannucci,et al. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status , 2015, Gut.
[67] M. Szyf,et al. Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness. , 2014, Carcinogenesis.
[68] F. Cameron,et al. Inflammation and MiR-21 Pathways Functionally Interact to Downregulate PDCD4 in Colorectal Cancer , 2014, PloS one.
[69] L. Hesson,et al. The evidence for functional non-CpG methylation in mammalian cells , 2014, Epigenetics.
[70] E. Giovannucci,et al. The role of vitamin D in reducing cancer risk and progression , 2014, Nature Reviews Cancer.
[71] D. Bikle,et al. Vitamin D metabolism, mechanism of action, and clinical applications. , 2014, Chemistry & biology.
[72] C. Morrison,et al. MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. , 2013, Gastroenterology.
[73] J. Feliu,et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis , 2013, Gut.
[74] P. Horváth,et al. CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells. , 2013, World journal of gastroenterology.
[75] H. Fessi,et al. Nano-encapsulation of Vitamin D3 Active Metabolites for Application in Chemotherapy: Formulation Study and in Vitro Evaluation , 2013, Pharmaceutical Research.
[76] J. Mathers,et al. Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa , 2012, Aging cell.
[77] J. Knight,et al. Vitamin D Intake Is Negatively Associated with Promoter Methylation of the Wnt Antagonist Gene DKK1 in a Large Group of Colorectal Cancer Patients , 2012, Nutrition and cancer.
[78] C. Boland,et al. A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer , 2012, PloS one.
[79] M. Veldhoen,et al. Dietary influences on intestinal immunity , 2012, Nature Reviews Immunology.
[80] A. Muñoz,et al. MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. , 2012, Human molecular genetics.
[81] Yanlei Ma,et al. Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation , 2012, International journal of cancer.
[82] M. Campbell,et al. Vitamin D has wide regulatory effects on histone demethylase genes , 2012, Cell cycle.
[83] M. Campbell,et al. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. , 2011, Human molecular genetics.
[84] R. Turner,et al. LINE-1 Hypomethylation During Primary Colon Cancer Progression , 2011, PloS one.
[85] G. Byrnes,et al. Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma , 2011, International journal of cancer.
[86] X. Geng,et al. S-Adenosylmethionine Inhibits the Growth of Cancer Cells by Reversing the Hypomethylation Status of c-myc and H-ras in Human Gastric Cancer and Colon Cancer , 2010, International journal of biological sciences.
[87] J. Reichrath,et al. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[88] C. Geisler,et al. Vitamin D controls T cell antigen receptor signaling and activation of human T cells , 2010, Nature Immunology.
[89] M. Ehrlich. DNA hypomethylation in cancer cells. , 2009, Epigenomics.
[90] Shingo Takagi,et al. Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b , 2009, Molecular Pharmacology.
[91] Yuzhuo Pan,et al. MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting The online version of this article (available at http://dmd.aspetjournals.org) contains supplemental material. , 2009, Drug Metabolism and Disposition.
[92] Shingo Takagi,et al. MicroRNA regulates human vitamin D receptor , 2009, International journal of cancer.
[93] Christian Pilarsky,et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. , 2009, Clinical chemistry.
[94] X. Chen,et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.
[95] Xuening Wang,et al. MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3 , 2009, Cell cycle.
[96] Emily J. Greenspan,et al. HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling , 2008, Cancer biology & therapy.
[97] S. Ogino,et al. LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer , 2008, International journal of cancer.
[98] M. Bitner-Glindzicz,et al. Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—A new metabolic disorder , 2008, Journal of Inherited Metabolic Disease.
[99] T. Veenstra,et al. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.
[100] I. Issaeva,et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development , 2007, Nature.
[101] Howard Y. Chang,et al. A histone H3 lysine 27 demethylase regulates animal posterior development , 2007, Nature.
[102] G. Natoli,et al. The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing , 2007, Cell.
[103] Manel Esteller,et al. The role of histone deacetylases (HDACs) in human cancer , 2007, Molecular oncology.
[104] R. Recker,et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.
[105] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[106] A. Muñoz,et al. SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications , 2005, British Journal of Cancer.
[107] Ivan V. Gregoretti,et al. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. , 2004, Journal of molecular biology.
[108] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[109] H. Cross,et al. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. , 2001, Biochemical and biophysical research communications.
[110] M. Szyf,et al. A mammalian protein with specific demethylase activity for mCpG DNA , 1999, Nature.
[111] J. Herman,et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[112] G. McVeigh,et al. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. , 1988, BMJ.
[113] C. Garland,et al. Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.
[114] M. Kerachian,et al. Long interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[115] Xiaoan Ruan,et al. Expression of VDR and CYP24A1 mRNA in human tumors , 2005, Cancer Chemotherapy and Pharmacology.
[116] David I. K. Martin,et al. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue , 2004, International Journal of Colorectal Disease.